This inventor holds 4 USPTO granted patents. Top assignee: Life Technologies Corporation. Active years: 1998-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2011
Title: Kevin P. Schifferli: Innovator in Peptide-Enhanced Transfections
Introduction
Kevin P. Schifferli is a notable inventor based in Germantown, MD (US). He has made significant contributions to the field of biotechnology, particularly in the area of transfection technologies. With a total of 4 patents to his name, Schifferli's work focuses on enhancing the efficiency of gene delivery systems.
Latest Patents
One of Schifferli's latest patents is centered around peptide-enhanced transfections. This invention provides compositions that are useful for transfecting eukaryotic cells. These compositions comprise nucleic acid complexes with peptides, which may be covalently coupled to a nucleic acid-binding group, along with cationic lipids or dendrimers as transfection agents. The invention also includes transfection compositions where a peptide is covalently linked to the transfection agent, such as lipid, cationic lipid, or dendrimer. The inclusion of peptides or modified peptides in these transfection compositions significantly enhances transfection efficiency. Additionally, methods for preparing these compositions and their applications as intracellular delivery agents and extracellular targeting agents are disclosed.
Career Highlights
Kevin P. Schifferli is currently employed at Life Technologies Corporation, where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing the capabilities of transfection technologies, which are crucial for various applications in genetic research and therapeutic development.
Collaborations
Throughout his career, Schifferli has collaborated with several talented individuals, including Pamela Hawley-Nelson and Jianqing Lan. These collaborations have contributed to the success of his projects and the advancement of the technologies he has developed.
Conclusion
Kevin P. Schifferli is a prominent inventor whose work in peptide-enhanced transfections has the potential to revolutionize gene delivery systems. His contributions to biotechnology continue to pave the way for advancements in genetic research and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile